GLP-1 Compounding: Lilly Takes Advertising Complaints To NAD

 
• By Sue Sutter
  
Woman on scale
Lilly is battling companies marketing compounded GLP-1 products for weight loss.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance